Cargando…
COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
Patients with cancer are among the most vulnerable groups of the COVID-19 pandemic, whereas vaccinations can represent a cornerstone in overcoming the pandemic itself. However, cancer patients were excluded from clinical trials for COVID-19 vaccinations, and thus the data on the immunogenicity and s...
Autores principales: | Cavanna, Luigi, Citterio, Chiara, Toscani, Ilaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473083/ https://www.ncbi.nlm.nih.gov/pubmed/34579285 http://dx.doi.org/10.3390/vaccines9091048 |
Ejemplares similares
-
Herpes Zoster Following COVID-19 Vaccination in Long-Term Breast Cancer Survivors
por: Toscani, Ilaria, et al.
Publicado: (2021) -
Global Seropositivity of Swine Leptospirosis: Systematic Review and Meta-Analysis
por: Gomes de Araújo, Hosaneide, et al.
Publicado: (2023) -
Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis
por: Xu, Wanqian, et al.
Publicado: (2023) -
Central venous catheterization in cancer patients with severe thrombocytopenia: Ultrasound-guide improves safety avoiding prophylactic platelet transfusion
por: Cavanna, Luigi, et al.
Publicado: (2020) -
Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis
por: Kang, Liangyu, et al.
Publicado: (2022)